These data indicate that IFN-γ in the TME was critical for immune surveillance and control of tumor growth as well as for mediating the ICB treatment response, and that the source of IFN-γ was mainly CD8+ T cells and partially CD4+ T cells. The gene discussed is CD4; the disease is neoplasm.